Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 52 (3), 421-434
- https://doi.org/10.1016/0090-1229(89)90157-8
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.The Journal of Experimental Medicine, 1987
- Effect of tumor necrosis factor alpha on mitogen-activated human B cells.The Journal of Experimental Medicine, 1987
- Lymphocyte Hormone ReceptorsAnnual Review of Immunology, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.The Journal of Experimental Medicine, 1986
- Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophagesBiochemical and Biophysical Research Communications, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- Effect of diet on survival and nephropathy of NZBNZW hybrid miceBiochemical Medicine, 1973